Role of NLRP3 in Parkinson's disease: Specific activation especially in dopaminergic neurons
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Guizhou Provincial Science and Technology Department (ZK[2023]-4904)
- Yulin Science and Technology Bureau
- National Natural Science Foundation of China (82260774)
This publication has 134 references indexed in Scilit:
- Expression and regulation of cryopyrin and related proteins in rheumatoid arthritis synoviumAnnals of the Rheumatic Diseases, 2005
- S -Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective FunctionScience, 2004
- NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory DisorderImmunity, 2004
- Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administrationAnnals of Neurology, 2003
- Critical role of microglial NADPH oxidase‐derived free radicals in the in vitro MPTP model of Parkinson's diseaseThe FASEB Journal, 2003
- The InflammasomeMolecular Cell, 2002
- Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposureAnnals of Neurology, 1999
- Mutations in the parkin gene cause autosomal recessive juvenile parkinsonismNature, 1998
- α-Synuclein in Lewy bodiesNature, 1997
- Effects of Enhanced Striatal Dopamine Turnover In Vivo on Glutathione OxidationClinical Neuropharmacology, 1994